http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Medtronic leverages data science to launch first-of-its-kind personalized insights program for people living with diabetes
-
Medtronic (MDT) Granted FDA Approval for Pacing the Heart's Natural Conduction System
-
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
-
Medtronic to webcast renal denervation investor & analyst briefing on November 7
-
Fortune and Great Place to Work® Name Medtronic one of the 'World's Best Workplaces™' in 2022
-
Cloud DX Grows Paramedic Deployments with Oxford County ON
-
Medtronic releases 2022 Integrated Performance Report
-
Medtronic (MDT) Granted FDA 510(k) Clearance for Expanded Indication of LINQ II
-
Medtronic receives FDA clearance for expanded indication of LINQ II™ insertable cardiac monitor for use in pediatric patients ages 2 and older
-
TCT 2022: SYMPLICITY HTN-3 trial data show sustained long-term blood pressure reductions with Medtronic renal denervation procedure
-
Titan Medical (TMDI) Enters Definitive Agreement with Medtronic (MDT)
-
Titan Medical Signs Definitive Agreement with Medtronic
-
Medtronic to appear at September investor conferences
-
Medtronic ADAPT study results published in The Lancet Diabetes & Endocrinology show improved glycemic control and treatment satisfaction among those using MiniMed™ 780G system¹, compared to ins
-
Medtronic announces partnership with BioIntelliSense for exclusive U.S. distribution of multi-parameter wearable for continuous remote patient monitoring from in-hospital to home
-
Medtronic completes acquisition of Affera
-
Cloud DX to Present on Teladoc Partnership and More at Emerging Growth Conference
-
Medtronic Extravascular ICD meets global pivotal clinical trial's safety and effectiveness endpoints
-
Medtronic reports first quarter fiscal 2023 financial results
-
Medtronic announces cash dividend for second quarter of fiscal year 2023
-
Medtronic to announce financial results for its first quarter of fiscal year 2023
-
Medtronic (MDT) Expands Health Equity Assistance Program for Colon Cancer Screening With Support from AWS
-
Medtronic expands Health Equity Assistance Program for colon cancer screening with support from Amazon Web Services; Completes first installation of donated GI Genius™ intelligent endoscopy modules
-
Medtronic (MDT) receives FDA clearance for next-generation UNiD™ Spine Analyzer with degenerative spine surgery predictive model
-
Medtronic receives FDA clearance for next-generation UNiD™ Spine Analyzer with degenerative spine surgery predictive model
-
Medtronic (MDT) announces co-promotion agreement with CathWorks, with path toward acquisition
-
Medtronic announces co-promotion agreement with CathWorks, with path toward acquisition
-
Medtronic (MDT) Appoints Lidia Fonseca to its Board
-
Medtronic Board appoints Lidia Fonseca as a new director
-
Cloud DX Completes Federal Project to Scale Up, Create Jobs, and Expand Intellectual Property (IP)
-
GE Healthcare, Medtronic Partnership Accelerates Global Access to Personalized Care by Delivering Advanced Patient Monitoring Solutions on the CARESCAPE Platform
-
Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference
-
Medtronic reports full year and fourth quarter fiscal year 2022 financial results; announces 8% dividend increase
-
Medtronic (MDT) and DaVita (DVA) to Form new Independent Kidney Technology Company
-
Medtronic and DaVita announce New Kidney Health Technology Company
-
Medtronic and DaVita announce new kidney health technology company
-
Medtronic to announce financial results for its fourth quarter and full fiscal year 2022
-
EuroPCR: Medtronic renal denervation system shows better blood pressure control with significantly more time in target range
-
Medtronic (MDT) Granted FDA Approval of Latest Generation of Drug-Eluting Coronary Stent System
-
Medtronic receives FDA approval for latest generation drug-eluting coronary stent system
-
Medtronic (MDT) completes acquisition of Intersect ENT (XENT)
-
Medtronic completes acquisition of Intersect ENT
-
Titan Medical Inc. (TMDI) Announces $2.6M Purchase Order from Medtronic (MDT)
-
Titan Medical Announces Purchase Order from Medtronic
-
Medtronic (MDT) and GE Healthcare (GE) announce a collaboration to meet growing need for outpatient care
-
GE Healthcare and Medtronic Announce a Collaboration to Meet Growing Need for Outpatient Care
-
Medtronic and GE Healthcare announce a collaboration to meet growing need for outpatient care
-
Medtronic (MDT) Appoints Laura Mauri as Chief Scientific, Medical and Regulatory Officer
-
Medtronic names new chief scientific, medical, and regulatory officer
-
ACC.22: Medtronic renal denervation system demonstrates significant blood pressure reduction through three years

